Preliminary Results From A Phase Ii Trial Of Docetaxel Before Castration With Degarelix In Men With Newly Diagnosed Metastatic Prostate Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2021)
摘要
116Background: Randomized trials have demonstrated a survival advantage to administering docetaxel (D) shortly after initiation of androgen deprivation therapy (ADT) in men with newly diagnosed hor...
更多查看译文
关键词
Degarelix,Androgen deprivation therapy,Docetaxel,Prostate cancer,Randomized controlled trial,Castration,Oncology,Medicine,Internal medicine,Newly diagnosed,Survival advantage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要